Related references
Note: Only part of the references are listed.Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study
Dominique P. Germain et al.
GENETICS IN MEDICINE (2019)
Impairment of cognitive function in ornithine transcarbamylase deficiency is global rather than domain-specific and is associated with disease onset, sex, maximum ammonium, and number of hyperammonemic events
Corinna Buerger et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2019)
Transatlantic combined and comparative data analysis of 1095 patients with urea cycle disordersA successful strategy for clinical research of rare diseases
Roland Posset et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2019)
Impact of Diagnosis and Therapy on Cognitive Function in Urea Cycle Disorders
Roland Posset et al.
ANNALS OF NEUROLOGY (2019)
A cross-sectional quantitative analysis of the natural history of Farber disease: an ultra-orphan condition with rheumatologic and neurological cardinal disease features
Matthias Zielonka et al.
GENETICS IN MEDICINE (2018)
Biochemical markers and neuropsychological functioning in distal urea cycle disorders
Susan E. Waisbren et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2018)
Quantitative clinical characteristics of 53 patients with MPS VII: a cross-sectional analysis
Matthias Zielonka et al.
GENETICS IN MEDICINE (2017)
Mutations in the Human Argininosuccinate Synthetase (ASS1) Gene, Impact on Patients, Common Changes, and Structural Considerations
Carmen Diez-Fernandez et al.
HUMAN MUTATION (2017)
Incidence, disease onset and short-term outcome in urea cycle disorders -cross-border surveillance in Germany, Austria and Switzerland
Susanne Nettesheim et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Prediction of phenotypic severity in mucopolysaccharidosis type IIIA
Suzan J. G. Knottnerus et al.
ANNALS OF NEUROLOGY (2017)
Neonatal mortality and outcome at the end of the first year of life in early onset urea cycle disorders-review and meta-analysis of observational studies published over more than 35 years
Peter Burgard et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2016)
Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disorders
Roland Posset et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2016)
Kinetic mutations in argininosuccinate synthetase deficiency: characterisation and in vitro correction by substrate supplementation
Carmen Diez-Fernandez et al.
JOURNAL OF MEDICAL GENETICS (2016)
An estimated glomerular filtration rate equation for the full age spectrum
Hans Pottel et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy
Claudia A. Chiriboga et al.
NEUROLOGY (2016)
The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype
Stefan Koelker et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2015)
The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation
Stefan Koelker et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2015)
Significant Hepatic Involvement in Patients with Ornithine Transcarbamylase Deficiency
Renata C. Gallagher et al.
JOURNAL OF PEDIATRICS (2014)
The incidence of urea cycle disorders
Marshall L. Summar et al.
MOLECULAR GENETICS AND METABOLISM (2013)
Insights into RNA Biology from an Atlas of Mammalian mRNA-Binding Proteins
Alfredo Castello et al.
CELL (2012)
T cell Activation Is Driven by an ADP-Dependent Glucokinase Linking Enhanced Glycolysis with Mitochondrial Reactive Oxygen Species Generation
Marcin M. Kaminski et al.
CELL REPORTS (2012)
Fast stable restricted maximum likelihood and marginal likelihood estimation of semiparametric generalized linear models
Simon N. Wood
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2011)
New insights into tetrahydrobiopterin pharmacodynamics from Pahenu1/2, a mouse model for compound heterozygous tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency
Florian B. Lagler et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Iron Regulatory Proteins Secure Mitochondrial Iron Sufficiency and Function
Bruno Galy et al.
CELL METABOLISM (2010)
Establishing a consortium for the study of rare diseases: The Urea Cycle Disorders Consortium
Jennifer Seminara et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Survival after treatment with phenylacetate and benzoate for urea-cycle disorders
Gregory M. Enns et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Unbiased recursive partitioning: A conditional inference framework
Torsten Hothorn et al.
JOURNAL OF COMPUTATIONAL AND GRAPHICAL STATISTICS (2006)
Bioenergetics in glutaryl-coenzyme A dehydrogenase deficiency
SW Sauer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)